Volume 20, Number 6—June 2014
Research
Short-Term Malaria Reduction by Single-Dose Azithromycin during Mass Drug Administration for Trachoma, Tanzania
Figure 1

Figure 1. Flowchart of participants in study of short-term malaria reduction by single-dose azithromycin (AZT) during mass drug administration (MDA) for trachoma, Tanzania, January 12–July 21, 2009AZT MDA (village-wide) and study panels show that 90% of persons who were intended to receive AZT received this drugTotal study participants with ≈1,000 in each group, shown in the study panel, contributed samples that are shown in the real-time PCR panel at each sampling timePercentages in the real-time PCR panel used values from the study panel as the denominator.
1Current affiliation: Pfizer, Inc., New York, New York, USA.